Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- PMID: 28700263
- DOI: 10.1056/NEJMx170011
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Erratum for
-
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous